Chemoinformaics analysis of 9-HYDROXY-4-(3,7-DIMETHYL-2,6-OCTADIENYLOXY)-PSORALEN
| Molecular Weight | 368.429 | nRot | 7 |
| Heavy Atom Molecular Weight | 344.237 | nRig | 18 |
| Exact Molecular Weight | 368.162 | nRing | 3 |
| Solubility: LogS | -5.448 | nHRing | 2 |
| Solubility: LogP | 6.176 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 15 |
| nHA | 5 | APOL | 56.753 |
| nHD | 0 | BPOL | 31.889 |
| QED | 0.4 |
| Synth | 2.974 |
| Natural Product Likeliness | 1.882 |
| NR-PPAR-gamma | 0.038 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.694 |
| Pgp-sub | 0.01 |
| HIA | 0.007 |
| CACO-2 | -4.696 |
| MDCK | 0.0000191 |
| BBB | 0.006 |
| PPB | 0.745451 |
| VDSS | 1.539 |
| FU | 0.157737 |
| CYP1A2-inh | 0.963 |
| CYP1A2-sub | 0.249 |
| CYP2c19-inh | 0.96 |
| CYP2c19-sub | 0.139 |
| CYP2c9-inh | 0.914 |
| CYP2c9-sub | 0.825 |
| CYP2d6-inh | 0.592 |
| CYP2d6-sub | 0.53 |
| CYP3a4-inh | 0.619 |
| CYP3a4-sub | 0.166 |
| CL | 13.907 |
| T12 | 0.111 |
| hERG | 0.038 |
| Ames | 0.162 |
| ROA | 0.193 |
| SkinSen | 0.172 |
| Carcinogencity | 0.734 |
| EI | 0.047 |
| Respiratory | 0.746 |
| NR-Aromatase | 0.826 |
| Antiviral | No |
| Prediction | 0.521405 |